Boostede proteasehæmmere, såsom darunavir/ ritonavir, udviser en højere resistensbarriere sammenlignet med andre grupper af antiretrovirale stoffer.
Boosted protease inhibitors, like darunavir/ ritonavir, show a higher barrier to resistance compared to other classes of antiretrovirals.